MENU
+Compare
MRSN
Stock ticker: NASDAQ
AS OF
Apr 24, 04:59 PM (EDT)
Price
$0.36
Change
-$0.03 (-7.69%)
Capitalization
45.15M

MRSN Mersana Therapeutics Forecast, Technical & Fundamental Analysis

Mersana Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing antibody-drug conjugates (ADCs) that offer a clinically meaningful benefit for cancer patients with unmet needs... Show more

Industry: #Biotechnology
MRSN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for MRSN with price predictions
Apr 23, 2025

MRSN in upward trend: price expected to rise as it breaks its lower Bollinger Band on March 31, 2025

MRSN may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In of 40 cases where MRSN's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where MRSN's RSI Indicator exited the oversold zone, of 46 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 65 cases where MRSN's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on April 17, 2025. You may want to consider a long position or call options on MRSN as a result. In of 91 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for MRSN just turned positive on April 11, 2025. Looking at past instances where MRSN's MACD turned positive, the stock continued to rise in of 46 cases over the following month. The odds of a continued upward trend are .

Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where MRSN advanced for three days, in of 270 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

Following a 3-day decline, the stock is projected to fall further. Considering past instances where MRSN declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for MRSN entered a downward trend on April 22, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (61.728) is normal, around the industry mean (14.056). P/E Ratio (0.000) is within average values for comparable stocks, (63.446). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.788). Dividend Yield (0.000) settles around the average of (0.025) among similar stocks. P/S Ratio (1.096) is also within normal values, averaging (252.992).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. MRSN’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. MRSN’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
MRSN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

MRSN is expected to report earnings to rise 76.64% to -19 cents per share on May 12

Mersana Therapeutics MRSN Stock Earnings Reports
Q1'25
Est.
$-0.19
Q4'24
Beat
by $0.04
Q3'24
Missed
by $0.18
Q2'24
Missed
by $0.03
Q1'24
Beat
by $0.02
The last earnings report on March 03 showed earnings per share of -10 cents, beating the estimate of -15 cents. With 1.86M shares outstanding, the current market capitalization sits at 45.15M.
A.I. Advisor
published General Information

General Information

a developer of antibody drug conjugates to improve patient outcomes in multiple oncology indications

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
840 Memorial Drive
Phone
+1 617 498-0020
Employees
123
Web
https://www.mersana.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NEXT7.360.16
+2.22%
NextDecade Corp
CLRO0.500.01
+2.02%
ClearOne
FLR34.440.56
+1.65%
Fluor Corp
CTAS207.691.85
+0.90%
Cintas Corp
FRBA13.70-0.43
-3.04%
First Bank

MRSN and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, MRSN has been loosely correlated with IGMS. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if MRSN jumps, then IGMS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MRSN
1D Price
Change %
MRSN100%
+2.39%
IGMS - MRSN
51%
Loosely correlated
-4.79%
INZY - MRSN
50%
Loosely correlated
-4.84%
CRNX - MRSN
47%
Loosely correlated
+3.55%
DYN - MRSN
45%
Loosely correlated
+8.78%
RGNX - MRSN
44%
Loosely correlated
+13.43%
More